Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 May 3;2(5):luae086.
doi: 10.1210/jcemcr/luae086. eCollection 2024 May.

Two Cases of Sitosterolemia Falsely Diagnosed as Familial Hypercholesterolemia: Could Digging Deeper Have Avoided Harm?

Simon-Pierre Guay  1   2   3 , Martine Paquette  1 , Chantal Blais  1 , Géraldine Gosse  1 , Alexis Baass  1   4
Affiliations
Case Reports

Two Cases of Sitosterolemia Falsely Diagnosed as Familial Hypercholesterolemia: Could Digging Deeper Have Avoided Harm?

Simon-Pierre Guay et al. JCEM Case Rep. .

Abstract

Sitosterolemia is a rare monogenic lipid disease characterized by the excessive uptake of phytosterols and their accumulation in blood and tissues. Clinically, it can present with hypercholesterolemia and xanthomas, often causing it to be misdiagnosed as familial hypercholesterolemia (FH). The diagnosis of sitosterolemia can easily be confirmed and distinguished from FH with a sterol profile and genetic investigations. Here, we report a sibship of 2 sisters with sitosterolemia initially misdiagnosed as FH. This case report illustrates the importance of considering rare conditions, such as sitosterolemia, as a differential diagnosis in patients with hypercholesterolemia, xanthomas, and hematologic anomalies. It also emphasizes the underdiagnosis of sitosterolemia and the benefits of using sterol profiles and genetic testing in the diagnostic process to initiate the appropriate therapy and avoid harm to patients.

Keywords: ABCG5; ezetimibe; macrothrombocytopenia; phytosterol; sitosterolemia.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Cholesterol concentration, platelet count, and mean platelet volume according to treatment. This figure shows the cholesterol concentrations, platelet count, and mean platelet volume over time according to treatment in patient 1 (panels A-C) and patient 2 (panels D-F). HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; Prava, pravastatin; Rosuva, rosuvastatin.
See this image and copyright information in PMC

References

    1. Othman RA, Myrie SB, Jones PJ. Non-cholesterol sterols and cholesterol metabolism in sitosterolemia. Atherosclerosis. 2013;231(2):291‐299. - PubMed
    1. Escolà-Gil JC, Quesada H, Julve J, et al. Sitosterolemia: diagnosis, investigation, and management. Curr Atheroscler Rep. 2014;16(7):424. - PubMed
    1. Yoo EG. Sitosterolemia: a review and update of pathophysiology, clinical spectrum, diagnosis, and management. Ann Pediatr Endocrinol Metab. 2016;21(1):7‐14. - PMC - PubMed
    1. Xia Y, Duan Y, Zheng W, et al. Clinical, genetic profile and therapy evaluation of 55 children and 5 adults with sitosterolemia. J Clin Lipidol. 2022;16(1):40‐51. - PubMed
    1. Civeira F, Castillo S, Alonso R, et al. Tendon xanthomas in familial hypercholesterolemia are associated with cardiovascular risk independently of the low-density lipoprotein receptor gene mutation. Arterioscler Thromb Vasc Biol. 2005;25(9):1960‐1965. - PubMed

Publication types

LinkOut - more resources